Healthtech Investors & VC Firms in Europe

1121 firms in this list, with a median first check of $540K. 275 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
PA PAI Partners AAKBAAWP13 people	88🔒	Paris	FR	Growth–Late Stage	$108M – $324M	+ Add to CRM
SE Seroba Life Sciences BMJMMLDJ13 people	88🔒	Dublin	IE	Seed–Late Stage	$540K – $7.6M	+ Add to CRM
IN InfraVia Capital Partners	88🔒	Paris	FR	Series C–Late Stage	—	+ Add to CRM
MA Masia CTPBACAN6 people · Follows rounds	88🔒	Barcelona	ES	Pre-Seed–Seed	$135K – $270K	+ Add to CRM
RE Redbus Ventures	88🔒	London	GB	Pre-Seed–Series A	—	+ Add to CRM
FO Fountain Healthcare Partners TPAKMREP8 people · Leads rounds	88🔒	Dublin	IE	Seed–Series B	$10.8M – $16.2M	+ Add to CRM
QU Quadrille Capital APRSVBAG14 people	88🔒	Paris	FR	Seed–Late Stage	—	+ Add to CRM
SO Soulmates Ventures HSLAVGMS14 people · Leads rounds	88🔒	Prague	CZ	Seed–Series A	$3.3M	+ Add to CRM
CA Capital Cell	88🔒	Barcelona	ES	Pre-Seed–Growth	—	+ Add to CRM
DE Delta Partners ANDBMRCJ6 people · Leads rounds	88🔒	Dublin	IE	Pre-Seed–Series B	$108K – $3.2M	+ Add to CRM
PO Possible Ventures CHCBTS3 people · Follows rounds	88🔒	Munich	DE	Pre-Seed–Series A	$100K – $5M	+ Add to CRM
TE TealTech Capital ИЗKDSNАС15 people · Leads rounds	88🔒	Moscow	RU	Seed–Growth	$1M	+ Add to CRM
EV Evio VC NRSGCMSB17 people	88🔒	Athens	SG	Pre-Seed–Seed	—	+ Add to CRM
HI Hikma Ventures LGAFSAAA14 people · Leads rounds	88🔒	London	GB	Seed–Late Stage	$5M	+ Add to CRM
HE Heliad AG CVDNFSJK13 people	88🔒	Frankfurt am Main	DE	Pre-Seed–Late Stage	$5.4M – $16.2M	+ Add to CRM
MA Maximon CWDKDTDG19 people	88🔒	Zug	CH	Pre-Seed–Series A	$11M	+ Add to CRM
BR Brunnur Ventures GP ÁBSASAEÞ9 people	88🔒	Reykjavik	IS	Pre-Seed–Series A	$1M – $3M	+ Add to CRM
EL Elbow Beach Capital ASBACGDG11 people · Leads rounds	88🔒	London	GB	Pre-Seed–Series A	$635K – $1.9M	+ Add to CRM
VI Viola Credit AGEFIVAB14 people · Follows rounds	88🔒	London	GB	Pre-Seed–Late Stage	$2M – $50M	+ Add to CRM
BA Backbone Ventures MSPBJRMK13 people · Leads rounds	88🔒	Zurich	CH	Pre-Seed–Seed	$330K – $440K	+ Add to CRM
ME Meridian Health Ventures DDTIPSMM13 people	88🔒	London	GB	Pre-Seed–Series A	—	+ Add to CRM
GI Gimv AJLTMMPV11 people · Leads rounds	88🔒	Antwerp	BE	Growth–Late Stage	$21M – $430M	+ Add to CRM
KE Kelvin Capital AHJMHLLH8 people	88🔒	Glasgow	GB	Seed–Late Stage	—	+ Add to CRM
RI River Capital LTLRAJCS14 people	88🔒	Liverpool	GB	Seed–Growth	$32K – $2.6M	+ Add to CRM

PAI Partners

ParisGrowth–Late Stage$108M – $324M

AAKBAAWP13 people

Seroba Life Sciences

DublinSeed–Late Stage$540K – $7.6M

BMJMMLDJ13 people

InfraVia Capital Partners

ParisSeries C–Late Stage

Masia

BarcelonaPre-Seed–Seed$135K – $270K

CTPBACAN6 people

Redbus Ventures

LondonPre-Seed–Series A

Fountain Healthcare Partners

DublinSeed–Series B$10.8M – $16.2M

TPAKMREP8 people

Quadrille Capital

ParisSeed–Late Stage

APRSVBAG14 people

Soulmates Ventures

PragueSeed–Series A$3.3M

HSLAVGMS14 people

Capital Cell

BarcelonaPre-Seed–Growth

Delta Partners

DublinPre-Seed–Series B$108K – $3.2M

ANDBMRCJ6 people

Possible Ventures

MunichPre-Seed–Series A$100K – $5M

CHCBTS3 people

TealTech Capital

MoscowSeed–Growth$1M

ИЗKDSNАС15 people

Evio VC

AthensPre-Seed–Seed

NRSGCMSB17 people

Hikma Ventures

LondonSeed–Late Stage$5M

LGAFSAAA14 people

Heliad AG

Frankfurt am MainPre-Seed–Late Stage$5.4M – $16.2M

CVDNFSJK13 people

Maximon

ZugPre-Seed–Series A$11M

CWDKDTDG19 people

Brunnur Ventures GP

ReykjavikPre-Seed–Series A$1M – $3M

ÁBSASAEÞ9 people

Elbow Beach Capital

LondonPre-Seed–Series A$635K – $1.9M

ASBACGDG11 people

Viola Credit

LondonPre-Seed–Late Stage$2M – $50M

AGEFIVAB14 people

Backbone Ventures

ZurichPre-Seed–Seed$330K – $440K

MSPBJRMK13 people

Meridian Health Ventures

LondonPre-Seed–Series A

DDTIPSMM13 people

Gimv

AntwerpGrowth–Late Stage$21M – $430M

AJLTMMPV11 people

Kelvin Capital

GlasgowSeed–Late Stage

AHJMHLLH8 people

River Capital

LiverpoolSeed–Growth$32K – $2.6M

LTLRAJCS14 people

Data sourced from public filings and firms' own websites — see our methodology.